Over the past three months, shares of Qiagen (NYSE:QGEN) moved lower by 5.06%. Before we understand the importance of debt, let us look at how much debt Qiagen has.
QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and hospitals
QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set new standards by using so-called nanoplates to process samples in two hours rather than the five hours required by other systems.